The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s renal denervation devices market report forecasts the renal denervation devices market size to grow to $1.32 Billion by 2027, with a CAGR (compound annual growth rate) of more than 33%.

Learn More On The Renal Denervation Devices Market Report 2023 – https://www.thebusinessresearchcompany.com/report/renal-denervation-devices-global-market-report#

Renal Denervation Devices Market Size Forecast
The global renal denervation devices market is expected to grow from $0.31 billion in 2022 to $0.42 billion in 2023 at a compound annual growth rate (CAGR) of 35.65%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, and affecting many every market across the globe. The market size is expected to reach $1.32 billion in 2027 at a CAGR of 33.23%.

Europe held the largest renal denervation devices market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Renal Denervation Devices Market Driver ­– Increase In The Prevalence Of Hypertension
According to a report issued in January 2023 by the Mississippi State Department of Health, a US-based Mississippi state health department, approximately 1 million adult Mississippians (43.9%) had high blood pressure in 2021. Between 2011 and 2021, the prevalence of hypertension in Mississippi increased by 11.7% (from 39.3% to 43.9%). MS had a hypertension prevalence that was 36.3% higher than the US average in 2021 (MS: 43.9%, US: 32.2%). As a result of the rising prevalence of hypertension, the market for renal denervation devices will develop.

Request for A Sample Of The Global Renal Denervation Devices Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10631&type=smp

Key Renal Denervation Devices Market Trend – Product Innovation
To enhance their position and obtain a competitive advantage, major businesses in the renal denervation devices market are focusing on producing innovative products. For example, ReCor Medical Inc., a medical device firm based in the United States, will launch the Paradise Ultrasound Renal Denervation System for the treatment of hypertension in October 2021. This technique uses non-focused ultrasound to treat hyperactive nerves leading to the kidney in a minimally invasive procedure. When compared to a sham surgery, the Paradise System has been found to successfully lower blood pressure.

Renal Denervation Devices Market Segment
1) By Product: Simplicity Renal Denervation System, EnligHTN, Vessix Renal Denervation System, Iberis Renal Sympathetic Denervation System, Paradise Renal Denervation System, Other Products
2) By Technology: Radio Frequency Ablation, Ultrasound Energy-Based RDN, Brachytherapy, Chemical Ablation, Other Technologies
3) By End-Users: Hospitals, Cardiovascular research centre, Other End-Users

Renal Denervation Devices Market Major Players and Strategies
Major players in the renal denervation devices market are Boston Scientific Corporation, CardioSonic Ltd., Kona Medical Inc., Medtronic plc, Mercator MedSystems, Inc., ReCor Medical, Abbott Laboratories, Ablative Solutions Inc., Terumo Corporation, Symple Surgical Inc., St. Jude Medical Inc., Johnson & Johnson Services Inc., Theragenics Corporation, Vascular Dynamics Inc., and Otsuka Holdings Co. Ltd.

Clinical Accelerator, a full-service contract research organisation based in the United Kingdom, teamed with Verve Medical in April 2022 to conduct a preliminary human feasibility study on their revolutionary medical device designed for people suffering from treatment-resistant hypertension. Verve Medical Inc. is a medical equipment manufacturer situated in the United States.

The Renal Denervation Devices Global Market Report 2023 covers regional data on renal denervation devices market size, renal denervation devices market trends and drivers, opportunities, strategies, and renal denervation devices market competitor analysis. The countries covered in the renal denervation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Renal denervation devices are minimally invasive medical devices used to treat hypertension (high blood pressure) after other treatments have failed. To increase blood flow to the kidneys, a catheter is inserted into the renal arteries and radiofrequency energy is used to ablate sympathetic nerves in the vessel wall.

View More Reports Related To The Renal Denervation Devices Market –
Blood Pressure Monitoring Devices Global Market Report 2023
Wearable Blood Pressure Monitors Global Market Report 2023
Renal Biomarkers Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: